NCT01272037 2026-03-18
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
228 trialsNCT05941520 2026-03-18
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT06184750 2026-03-18
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT07478016 2026-03-17
EXIST
Thomas Jefferson University
Recruiting
NCT06075953 2026-03-16
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
QuantumLeap Healthcare Collaborative
Phase 2 Recruiting
NCT03909282 2026-03-12
NORDIS
Stanford University
Phase NA Recruiting
NCT06218303 2026-03-12
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
University of Pittsburgh
Phase 1 Recruiting
NCT01266642 2026-03-11
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06982313 2026-03-11
Babytam long
Ente Ospedaliero Ospedali Galliera
Completed
NCT01349322 2026-03-05
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Radiation Therapy Oncology Group
Phase 3 Active not recruiting
NCT03077841 2026-03-05
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer
M.D. Anderson Cancer Center
Phase 2/3 Suspended
NCT04144023 2026-03-05
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
Mayo Clinic
Phase 1 Recruiting
NCT06617455 2026-03-02
VEnT
University of Michigan Rogel Cancer Center
Phase 2 Terminated
NCT06868238 2026-02-18
Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)
University of Florida
Phase 2 Withdrawn
NCT06350500 2026-02-17
A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
Roswell Park Cancer Institute
Phase NA Recruiting
NCT07408856 2026-02-13
CAN1012 in OED, DCIS, and LCIS.
Providence Health & Services
Phase 1 Not yet recruiting
NCT00907868 2026-02-05
BONBIS
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Active not recruiting
NCT03495011 2026-02-02
MRI Characterization of Mammographically Detected DCIS
University of Washington
Active not recruiting
NCT05340673 2026-01-28
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer
City of Hope Medical Center
Phase 1 Active not recruiting
NCT05755269 2026-01-28
Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women
Mayo Clinic
Recruiting
NCT02926911 2026-01-27
COMET
Alliance Foundation Trials, LLC.
Phase NA Active not recruiting
NCT03878342 2026-01-23
ROMANCE
UNICANCER
Phase NA Active not recruiting
NCT04494945 2026-01-23
Identifying and Caring for Individuals With Inherited Cancer Syndrome
OHSU Knight Cancer Institute
Phase NA Recruiting
NCT04959474 2026-01-23
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
Thomas Jefferson University
Phase NA Recruiting
NCT06388304 2026-01-21
THRIVE
University of Colorado, Boulder
Phase NA Completed
NCT03664778 2026-01-13
Abbreviated Breast MRI After Cancer Treatment
University of Pennsylvania
Completed
NCT05023967 2026-01-05
Metformin and Nightly Fasting in Women With Early Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT03345420 2025-12-30
NOVEMBER
University of Utah
Phase 2 Completed
NCT00165256 2025-12-29
Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT00757302 2025-12-22
Intraoperative Gamma Camera for Breast Cancer Surgery
University Hospital, Strasbourg, France
Phase 3 Completed
NCT04537312 2025-12-22
Prospective Pilot Study of Robot-assisted Nipple Sparing Mastectomy (RNSM)
Ohio State University Comprehensive Cancer Center
Phase NA Active not recruiting
NCT02352883 2025-12-19
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Eastern Cooperative Oncology Group
Phase NA Active not recruiting
NCT07292246 2025-12-18
ATHENA I
Mediterraneo Hospital
Phase NA Recruiting
NCT01245712 2025-12-17
Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06903468 2025-12-15
Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions
University of Florida
Phase NA Recruiting
NCT06961955 2025-12-09
FAST NOVEMBER
University of Utah
Phase 2 Recruiting
NCT06185205 2025-11-21
ASHBY
Virginia Commonwealth University
Phase 2 Recruiting
NCT07178665 2025-11-14
Pilot Trial of Preop Partial Radiation in Breast Cancer Patients
Rutgers, The State University of New Jersey
Phase 1 Suspended
NCT03979508 2025-11-12
Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer
Mayo Clinic
Phase 2 Terminated
NCT00556907 2025-11-06
Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast
University of Southern California
Phase NA Terminated
NCT04169542 2025-10-27
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
M.D. Anderson Cancer Center
Recruiting
NCT05900986 2025-10-16
LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer
Integro Theranostics
Phase 1/2 Active not recruiting
NCT03546972 2025-10-14
Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT04009044 2025-10-09
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast
Northwestern University
Phase 2 Active not recruiting
NCT00874458 2025-09-30
MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ
Centre Antoine Lacassagne
Phase NA Completed
NCT03535506 2025-09-26
WI223281
Georgetown University
Phase 2 Terminated
NCT07095114 2025-09-18
A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
Barbara Ann Karmanos Cancer Institute
Phase NA Recruiting
NCT04084730 2025-09-16
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT01841749 2025-09-12
CINNAMOME
Institut Bergonié
Completed
NCT06257888 2025-09-11
NAVIMOZ
AC Camargo Cancer Center
Completed